Login / Signup

Key challenges for in vitro testing of tobacco products for regulatory applications: Recommendations for dosimetry.

Jacqueline Miller-HoltHolger BehrsingIan CrooksRodger CurrenKubilay DemirJeremie GafnerGene GillmanMichael HollingsRobert LeveretteMichael OldhamLiam SimmsLeon F StankowskiDavid ThorneRoman WieczorekMartha M Moore
Published in: Drug testing and analysis (2022)
The Institute for In Vitro Sciences (IIVS) is sponsoring a series of workshops to develop recommendations for optimal scientific and technical approaches for conducting in vitro assays to assess potential toxicity within and across tobacco and various next-generation products (NGPs) including heated tobacco products (HTPs) and electronic nicotine delivery systems (ENDSs). This publication was developed by a working group of the workshop members in conjunction with the sixth workshop in that series entitled "Dosimetry for conducting in vitro evaluations" and focuses on aerosol dosimetry for aerosol exposure to combustible cigarettes, HTP, and ENDS aerosolized tobacco products and summarizes the key challenges as well as documenting areas for future research.
Keyphrases
  • smoking cessation
  • oxidative stress
  • clinical practice
  • monte carlo
  • transcription factor
  • high throughput
  • risk assessment